Potential biological functions and future perspectives of sialylated milk oligosaccharides

Thuy Le Lam Nguyen,Dung Van Nguyen,Kyung-Sun Heo
DOI: https://doi.org/10.1007/s12272-024-01492-3
2024-04-02
Archives of Pharmacal Research
Abstract:Sialyllactoses (SLs) primarily include sialylated human milk oligosaccharides (HMOs) and bovine milk oligosaccharides (BMOs). First, the safety assessment of 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL) revealed low toxicity in various animal models and human participants. SLs constitute a unique milk component, highlighting the essential nutrients and bioactive components crucial for infant development, along with numerous associated health benefits for various diseases. This review explores the safety, biosynthesis, and potential biological effects of SLs, with a specific focus on their influence across various physiological systems, including the gastrointestinal system, immune disorders, rare genetic disorders (such as GNE myopathy), cancers, neurological disorders, cardiovascular diseases, diverse cancers, and viral infections, thus indicating their therapeutic potential.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?